Combining PCI and CABG: the role of hybrid revascularization
| Autor: | Tyffany P Chen, Kelly D. Green, Donald R Lynch, David Zhao |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Hybrid coronary revascularization medicine.medical_treatment Vein graft Coronary Disease Revascularization Article Coronary artery disease Percutaneous Coronary Intervention Internal medicine medicine Humans cardiovascular diseases Coronary Artery Bypass business.industry Patient Selection Percutaneous coronary intervention Drug-Eluting Stents Hybrid approach medicine.disease Surgery surgical procedures operative Drug-eluting stent Conventional PCI Cardiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | Current cardiology reports. 15(4) |
| ISSN: | 1534-3170 |
| Popis: | Hybrid coronary revascularization combines the benefits of both percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in the treatment of multivessel coronary artery disease (CAD) by combining the benefits of the LIMA-to-LAD graft and drug eluting stent (DES) to non-LAD regions. Through this approach, a patient receives the long-term benefit of the LIMA graft and avoids the morbidity of a full sternotomy and saphenous vein grafts. Available data related to outcomes following hybrid revascularization is limited to small studies. In this review we seek to provide an overview of hybrid revascularization in the era of modern drug eluting stent technology, discuss appropriate patient selection, and comment on future trial design. Additionally, we review the recent literature pertaining to the hybrid approach. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink